Search

Lan Wang

from San Jose, CA
Age ~46
Get Report
Related to:
Changliang Wang, 60Jin Wang, 54Tong Susu Wang, 62Jin H Hwang, 51Mei Gong, 64
Connected to:
Adele R Wang, 107Aiyuan Wang, 52Akiet Wang, 74Alene P Wang, 52Amanda K Wang, 46Amei Wang, 61Amity H Wang, 70Amy Wang, 59Anastasia S Wang, 85Ange Wang, 35

Lan Wang Phones & Addresses

  • 5140 Durango Ct, San Jose, CA 95118
  • Bellevue, WA
  • Sunnyvale, CA
  • Chicago, IL
  • Kiona, WA
  • Medford, MA
  • Boston, MA

Professional Records

Lawyers & Attorneys

Lan Wang Photo 1

Lan Wang - Lawyer

View page
Address:
Freshfields Bruckhaus Deringer LLP
(106) 505-3448 (Office)
Licenses:
New York - Currently registered 2012
Education:
The University of Chicago Law School
Lan Wang Photo 2

Lan Wang - Lawyer

View page
Specialties:
Police Law and Litigation
Civil Rights Defense
ISLN:
912506683
Admitted:
1996
University:
University of California, Irvine, B.A., 1993
Law School:
University of California, Hastings College of the Law, J.D., 1996

Medicine Doctors

Lan Wang Photo 3

Lan Lan L. Wang

View page
Specialties:
Psychiatry
Work:
Arcadia Mental Health Center
330 E Live Oak Ave, Arcadia, CA 91006
(626) 821-5858 (phone)
Education:
Medical School
Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71)
Graduated: 1991
Conditions:
Anxiety Dissociative and Somatoform Disorders
Anxiety Phobic Disorders
Attention Deficit Disorder (ADD)
Bipolar Disorder
Depressive Disorders
Languages:
Chinese
English
Spanish
Tagalog
Vietnamese
Description:
Dr. Wang graduated from the Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71) in 1991. She works in Arcadia, CA and specializes in Psychiatry.
Lan Wang Photo 4

Lan Wang

View page
Specialties:
Anatomic Pathology & Clinical Pathology, Hematology
Work:
Hackensack UMC Mountainside Pathology
1 Bay Ave Ground Fl, Montclair, NJ 07042
(973) 429-6164 (phone), (973) 429-6992 (fax)

Cancer Genetics Inc
201 State Rt 17 FL 2, Rutherford, NJ 07070
(201) 528-9200 (phone), (201) 528-9201 (fax)
Education:
Medical School
China Med Univ, Shenyang City, Liaoning, China
Graduated: 1993
Languages:
English
Description:
Dr. Wang graduated from the China Med Univ, Shenyang City, Liaoning, China in 1993. She works in Montclair, NJ and 1 other location and specializes in Anatomic Pathology & Clinical Pathology and Hematology.
Lan Wang Photo 5

Lan Sun Wang

View page
Specialties:
Internal Medicine
Gastroenterology
Education:
Columbia University (2006)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lan Wang
Chief Executive
Interligence
Elementary and Secondary Schools
4327 239Th Pl S.e., Bellevue, WA 98029
Lan Wang
Chief Executive
Interligence
Elementary and Secondary Schools
4327 239Th Pl S.e., Bellevue, WA 98029
Lan Wang
Owner
Stree-Free Networkers
Ret Mail-Order House
730 Sirica Ct, San Jose, CA 95138
Lan Wang
Managing
Prospective Edge LLC
Education Consulting · Investment Business · Nonclassifiable Establishments
3182 Campus Dr, San Mateo, CA 94403
Lan Wang
President
NUMERICALSTUDIO CORPORATION
14705 NE 37 Pl #B18, Bellevue, WA 98007

Publications

Isbn (Books And Publications)

The Blue and the Black

View page
Author

Lan Wang

ISBN #

0896446662

Us Patents

Air-Fuel Imbalance Detection Based On Zero-Phase Filtering

View page
US Patent:
7900615, Mar 8, 2011
Filed:
Oct 1, 2008
Appl. No.:
12/243045
Inventors:
Zhong Wang - Bellevue WA, US
Lan Wang - Troy MI, US
Ian J. Mac Ewen - White Lake MI, US
Igor Anilovich - Walled Lake MI, US
Steven Ward Majors - Howell MI, US
Cheol S. Lee - Ann Arbor MI, US
International Classification:
F02D 41/00
US Classification:
123672, 701109
Abstract:
A control system comprising an oxygen sensor that generates an oxygen signal based on an oxygen concentration level in an exhaust gas of an engine, a filtering module that determines a filtered signal based on the oxygen signal, and an air-fuel imbalance detection module that detects an air-fuel imbalance in the engine based on the oxygen signal and the filtered signal. A method comprising generating an oxygen signal based on an oxygen concentration level in an exhaust gas of an engine, determining a filtered signal based on the oxygen signal, and detecting an air-fuel imbalance in the engine based on the oxygen signal and the filtered signal.

Noise Minimization For Evaporative Canister Ventilation Valve Cleaning

View page
US Patent:
7950375, May 31, 2011
Filed:
Jul 16, 2008
Appl. No.:
12/174109
Inventors:
Zhong Wang - Bellevue WA, US
Tony T. Hoang - Warren MI, US
Lan Wang - Troy MI, US
Gary L. Rogers - Davison MI, US
Scott A. Kegebein - Brighton MI, US
William R. Cadman - Fenton MI, US
International Classification:
F02D 41/00
F02D 33/02
US Classification:
123520
Abstract:
A control system comprising a detection module that detects at least one of a vehicle speed and an engine speed and a canister vent valve control module that selectively modulates the canister vent valve based on at least one of the vehicle speed and the engine speed. A method comprising detecting at least one of a vehicle speed and an engine speed and selectively modulating a canister vent valve based on at least one of the vehicle speed and the engine speed.

Fuel Door Sensor Diagnostic Systems And Methods

View page
US Patent:
8000856, Aug 16, 2011
Filed:
Jan 9, 2009
Appl. No.:
12/351247
Inventors:
John F. Larsen - Campbellcroft, CA
Zhong Wang - Bellevue WA, US
Michael Pickett - Ajax, CA
Lan Wang - Troy MI, US
International Classification:
G01M 17/00
G06F 7/00
US Classification:
701 34, 701 29, 701 31, 701 49
Abstract:
A diagnostic system for a vehicle comprises a refueling indicator module and a diagnostic module. The refueling indicator module selectively indicates when a refueling event occurs. The diagnostic module selectively diagnoses a fault in a fuel door position sensor when the fuel door position sensor indicates that a fuel door is in one of an open position for less than a first predetermined period when the refueling event occurs and a closed position for greater than a second predetermined period when the refueling event occurs.

Benzoxazepin P13K Inhibitor Compounds And Methods Of Use

View page
US Patent:
8242104, Aug 14, 2012
Filed:
Sep 27, 2010
Appl. No.:
12/890812
Inventors:
Nicole Blaquiere - South San Francisco CA, US
Steven Do - South San Francisco CA, US
Danette Dudley - South San Francisco CA, US
Adrian Folkes - Basel, CH
Robert Heald - Harlow, GB
Timothy Heffron - South San Francisco CA, US
Mark Jones - Harlow, GB
Aleksandr Kolesnikov - South San Francisco CA, US
Chudi Ndubaku - South San Francisco CA, US
Alan G. Olivero - South San Francisco CA, US
Stephen Price - Harlow, GB
Steven Staben - South San Francisco CA, US
Lan Wang - South San Francisco CA, US
Assignee:
F. Hoffman-La Roche AG - Basel
International Classification:
A61K 31/553
C07D 498/04
C07D 498/14
US Classification:
5142111, 51421112, 540548
Abstract:
Benzoxazepin compounds of Formula I, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Zis CRor N; Zis CRor N; Zis CRor N; Zis CRor N; and B is a pyrazolyl, imidazolyl, or triazolyl ring fused to the benzoxepin ring, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Benzoxazepin Pi3K Inhibitor Compounds And Methods Of Use

View page
US Patent:
8343955, Jan 1, 2013
Filed:
May 22, 2012
Appl. No.:
13/477587
Inventors:
Nicole Blaquiere - South San Francisco CA, US
Steven Do - South San Francisco CA, US
Danette Dudley - South San Francisco CA, US
Adrian Folkes - Basel, CH
Robert Heald - Harlow, GB
Timothy Heffron - South San Francisco CA, US
Mark Jones - Harlow, GB
Aleksandr Kolesnikov - South San Francisco CA, US
Chudi Ndubaku - South San Francisco CA, US
Alan G. Olivero - South San Francisco CA, US
Stephen Price - Harlow, GB
Steven Staben - South San Francisco CA, US
Lan Wang - South San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 31/553
US Classification:
5142111
Abstract:
Benzoxazepin compounds of Formula I, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Zis CRor N; Zis CRor N; Zis CRor N; Zis CRor N; and B is a pyrazolyl, imidazolyl, or triazolyl ring fused to the benzoxepin ring, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Benzoxazepin Pi3K Inhibitor Compounds And Methods Of Use

View page
US Patent:
8586574, Nov 19, 2013
Filed:
Nov 20, 2012
Appl. No.:
13/681763
Inventors:
Steven Do - San Jose CA, US
Danette Dudley - Pacifica CA, US
Adrian Folkes - Slough, GB
Robert Heald - Harlow, GB
Timothy Heffron - Burlingame CA, US
Mark Jones - Harlow, GB
Aleksandr Kolesnikov - San Francisco CA, US
Chudi Ndubaku - San Francisco CA, US
Alan G. Olivero - Half Moon Bay CA, US
Stephen Price - Harlow, GB
Steven Staben - San Francisco CA, US
Lan Wang - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 31/553
C07D 498/04
C07D 498/14
US Classification:
5142111, 51421112, 540548
Abstract:
Benzoxazepin compounds of Formula I, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Zis CRor N; Zis CRor N; Zis CRor N; Zis CRor N; and B is a pyrazolyl, imidazolyl, or triazolyl ring fused to the benzoxepin ring, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Inhibitors Of Iap

View page
US Patent:
20110077265, Mar 31, 2011
Filed:
Apr 29, 2008
Appl. No.:
12/598027
Inventors:
John A. Flygare - Burlingame CA, US
Frederick Cohen - San Francisco CA, US
Kurt Deshayes - San Francisco CA, US
Michael F. T. Koehler - Palo Alto CA, US
Lewis J. Gazzard - Belmont CA, US
Lan Wang - Foster City CA, US
Chudi Ndubaku - San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 31/437
C07D 417/14
C07D 513/04
C07D 403/12
C12N 5/071
C07K 2/00
A61K 31/4545
A61K 31/433
A61K 31/4025
A61K 31/427
A61P 35/00
US Classification:
514301, 546187, 548127, 546114, 548518, 548195, 435375, 530408, 530409, 514316, 514361, 514422, 514371
Abstract:
The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds having the general formula U1-M-U2 wherein M is a linking group covalently joining R2, R3, R4 or R5 of U1 to an R2, R3, R4 or R5 group of U2; U1 and U2 have the general formula (I) and G, X1, X2, R2, R3, R3′, R4, R4′ and R5, are as described herein.

Tricyclic Pi3K Inhibitor Compounds And Methods Of Use

View page
US Patent:
20120171199, Jul 5, 2012
Filed:
Dec 15, 2011
Appl. No.:
13/326524
Inventors:
Jennafer Dotson - Belmont CA, US
Robert Andrew Heald - , US
Timothy Heffron - Burlingame CA, US
Graham Elgin Jones - , US
Sussie Lerche Krintel - , US
Neville James McLean - , US
Chudi Ndubaku - San Francisco CA, US
Alan G. Olivero - Half Moon Bay CA, US
Laurent Salphati - San Francisco CA, US
Lan Wang - Foster City CA, US
BinQing Wei - Belmont CA, US
International Classification:
A61K 31/5383
C07D 491/147
C07D 498/14
C07D 487/14
C07D 498/22
A61K 31/5386
A61K 31/5377
A61P 35/00
A61P 29/00
A61P 37/02
A61P 25/00
A61P 9/00
A61P 1/16
A61P 31/12
A61P 7/00
A61P 3/10
A61P 37/04
A61P 35/02
C07D 471/14
C07D 495/14
A61K 39/395
US Classification:
4241331, 544115, 544 73, 544 71, 544 74, 5142302, 5142332, 5142328
Abstract:
Tricyclic PI3k inhibitor compounds of Formula I with anti-cancer activity, anti-inflammatory activity, or immunoregulatory properties, and more specifically with PI3 kinase modulating or inhibitory activity are described. Methods are described for using the tricyclic PI3K inhibitor compounds of Formula I for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, organisms, or associated pathological conditions.Formula I compounds include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof. The dashed lines indicate an optional double bond, and at least one dashed line is a double bond. The substituents are as described.
Control profile
Lan Wang from San Jose, CA, age ~46 Get Report